NO323553B1 - Fremgangsmate for tilvirkning og bruk av pyrrolopyrimidinon-derivater - Google Patents

Fremgangsmate for tilvirkning og bruk av pyrrolopyrimidinon-derivater Download PDF

Info

Publication number
NO323553B1
NO323553B1 NO20023823A NO20023823A NO323553B1 NO 323553 B1 NO323553 B1 NO 323553B1 NO 20023823 A NO20023823 A NO 20023823A NO 20023823 A NO20023823 A NO 20023823A NO 323553 B1 NO323553 B1 NO 323553B1
Authority
NO
Norway
Prior art keywords
ch2ch2ch3
pyrrolo
dihydro
ylsulfonyl
pyrimidin
Prior art date
Application number
NO20023823A
Other languages
English (en)
Norwegian (no)
Other versions
NO20023823D0 (no
NO20023823L (no
Inventor
Dae-Kee Kim
Ju Young Lee
Do Hyun Ryu
Nam Kyu Lee
Suk Ho Lee
Nam-Ho Kim
Jae-Sun Kim
Je Ho Ryu
Jin-Young Choi
Guang-Jin Im
Won-Son Choi
Tae Kon Kim
Hoon Cha
Original Assignee
Sk Chemicals Co Ltd
In2Gen Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sk Chemicals Co Ltd, In2Gen Co Ltd filed Critical Sk Chemicals Co Ltd
Publication of NO20023823D0 publication Critical patent/NO20023823D0/no
Publication of NO20023823L publication Critical patent/NO20023823L/no
Publication of NO323553B1 publication Critical patent/NO323553B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO20023823A 2000-02-17 2002-08-13 Fremgangsmate for tilvirkning og bruk av pyrrolopyrimidinon-derivater NO323553B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20000007625A KR100358083B1 (ko) 2000-02-17 2000-02-17 피롤로피리미디논 유도체와 이의 제조방법, 그리고 이의용도
PCT/KR2001/000227 WO2001060825A1 (en) 2000-02-17 2001-02-15 Pyrrolopyrimidinone derivatives, process of preparation and use

Publications (3)

Publication Number Publication Date
NO20023823D0 NO20023823D0 (no) 2002-08-13
NO20023823L NO20023823L (no) 2002-10-09
NO323553B1 true NO323553B1 (no) 2007-06-11

Family

ID=19647449

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023823A NO323553B1 (no) 2000-02-17 2002-08-13 Fremgangsmate for tilvirkning og bruk av pyrrolopyrimidinon-derivater

Country Status (23)

Country Link
US (1) US6962911B2 (es)
EP (1) EP1257553B1 (es)
JP (1) JP4845076B2 (es)
KR (1) KR100358083B1 (es)
CN (1) CN1312153C (es)
AT (1) ATE267829T1 (es)
AU (2) AU2001236140B9 (es)
BR (1) BRPI0108395B8 (es)
CA (1) CA2400268C (es)
DE (1) DE60103508T2 (es)
DK (1) DK1257553T3 (es)
ES (1) ES2222344T3 (es)
HU (1) HU230344B1 (es)
IL (2) IL151234A0 (es)
MX (1) MXPA02007942A (es)
NO (1) NO323553B1 (es)
NZ (1) NZ520842A (es)
PL (1) PL210796B1 (es)
PT (1) PT1257553E (es)
RU (1) RU2263676C2 (es)
TR (1) TR200402101T4 (es)
WO (1) WO2001060825A1 (es)
ZA (1) ZA200206587B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100358083B1 (ko) * 2000-02-17 2002-10-25 에스케이케미칼주식회사 피롤로피리미디논 유도체와 이의 제조방법, 그리고 이의용도
EP1362858A1 (en) * 2002-05-15 2003-11-19 SK Chemicals Co., Ltd. Pyrrolopyrimidinone derivates, process of preparation and use
DE10229778A1 (de) * 2002-07-03 2004-01-29 Bayer Ag Neue Verwendung von Imidazotriazinonen
FR2842809A1 (fr) * 2002-07-26 2004-01-30 Greenpharma Sas NOUVELLES PYRAZOLO[1,5-a]-1,3,5-TRIAZINES SUBSTITUEES ET LEURS ANALOGUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION
CN100374441C (zh) * 2003-06-06 2008-03-12 天津倍方科技发展有限公司 二氢吡咯[2,3-d]嘧啶-4-酮衍生物,其制备方法及其制药用途
TW200745106A (en) * 2005-10-03 2007-12-16 Astrazeneca Ab Chemical compounds
KR20080003599A (ko) * 2006-07-03 2008-01-08 에스케이케미칼주식회사 피롤로피리미디논 유도체의 겐티세이트 염 및 이의제조방법
ES2610398T3 (es) * 2006-07-03 2017-04-27 Sk Chemicals, Co., Ltd. Sales de derivados de pirrolopirimidinona y procedimiento para su preparación
KR101002490B1 (ko) * 2007-06-09 2010-12-17 동아제약주식회사 유데나필을 유효성분으로 함유하는 만성 심부전증 치료용약학적 조성물
MX358697B (es) 2009-10-16 2018-08-31 Melinta Therapeutics Inc Compuestos antimicrobianos y metodos para fabricar y utilizar los mismos.
US9193731B2 (en) 2009-10-16 2015-11-24 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
JP6274723B2 (ja) 2009-10-16 2018-02-07 メリンタ セラピューティクス,インコーポレイテッド 抗微生物性化合物および抗微生物性化合物の製造方法および使用方法
KR101377178B1 (ko) 2010-04-05 2014-03-26 에스케이케미칼주식회사 Pde5 억제제를 함유하는 피부 주름 개선용 조성물
CN102372730B (zh) * 2010-08-19 2014-03-26 山东轩竹医药科技有限公司 桥环取代的磷酸二酯酶抑制剂
CN102134242B (zh) * 2011-01-21 2013-08-28 浙江大德药业集团有限公司 一种用于治疗阳痿的快速长效的化合物
TWI490220B (zh) * 2011-04-04 2015-07-01 Sk Chemicals Co Ltd 包含pde5抑制劑之用於減少皮膚皺紋之組成物
EA201391536A1 (ru) * 2011-04-15 2014-08-29 Мелинта Терапьютикс, Инк. Противомикробные соединения и способы их получения и применения
CN103826638B (zh) * 2011-09-09 2015-11-25 Sk化学公司 含有pde5 抑制剂的减少皮肤皱纹的组合物
US9750743B2 (en) 2012-12-04 2017-09-05 Aribio Inc. Composition comprising phosphodiesterase type 5 inhibitor for inhibiting apoptosis of nerve cells
WO2015035426A1 (en) 2013-09-09 2015-03-12 Melinta Therapeutics, Inc. Antimicrobial compunds and methods of making and using the same
MX2016003046A (es) 2013-09-09 2016-09-08 Melinta Therapeutics Inc Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos.
JP2018507881A (ja) 2015-03-11 2018-03-22 メリンタ セラピューティクス,インコーポレイテッド 抗微生物化合物ならびにこれらを作製および使用する方法
CN104744478B (zh) * 2015-03-20 2016-08-24 中国人民解放军第二军医大学 一种防治辐射损伤的化合物、单晶及其制备方法和应用
US10570137B2 (en) * 2015-11-16 2020-02-25 Topadur Pharma Ag 2-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodiesterase inhibitors and uses thereof
BR112019024300A2 (pt) * 2017-05-22 2020-06-16 Topadur Pharma Ag Ativadores de guanilato ciclase solúvel com modo duplo de ação e inibidores da fosfodiesterase e usos dos mesmos
CN112566670A (zh) 2018-08-06 2021-03-26 尼科斯股份有限公司 一氧化氮释放第5型磷酸二酯酶抑制剂
JP2022509815A (ja) 2018-11-28 2022-01-24 トパデュール ファルマ アーゲー 新規の二重作用型可溶性グアニル酸シクラーゼ活性化剤およびホスホジエステラーゼ阻害剤とその使用法
KR102271305B1 (ko) 2020-05-21 2021-06-30 주식회사 아리바이오 치매 예방 및 치료용 조성물
WO2021245192A1 (en) 2020-06-04 2021-12-09 Topadur Pharma Ag Novel dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof
CN111825593B (zh) * 2020-08-19 2023-04-07 上海成澄科技有限公司 3-氨基吡咯-2-甲酰胺类化合物的合成方法
KR102272907B1 (ko) 2020-11-05 2021-07-05 주식회사 아리바이오 치매 예방 및 치료용 조성물
KR102272910B1 (ko) 2021-01-28 2021-07-06 주식회사 아리바이오 당뇨병을 동반한 치매 예방 및 치료용 조성물
KR20220140960A (ko) 2021-04-12 2022-10-19 주식회사 아리바이오 당뇨병을 동반한 치매 예방 및 치료용 조성물
KR20220146095A (ko) 2021-04-23 2022-11-01 주식회사 아리바이오 Pde5 억제제와 글루코코르티코이드 수용체 길항제 병용투여를 통한 치매 예방 및 치료용 조성물
KR102311224B1 (ko) 2021-04-23 2021-10-13 주식회사 아리바이오 Pde5 억제제와 글루코코르티코이드 수용체 길항제 병용투여를 통한 치매 예방 및 치료용 조성물
WO2023052407A1 (en) 2021-09-29 2023-04-06 Topadur Pharma Ag Topical compositions of 2-phenyl-3,4-dihydropyrrolo[2,l-f] [1,2,4]triazinone derivatives and uses thereof
WO2023166013A1 (en) 2022-03-02 2023-09-07 Topadur Pharma Ag Topical compositions and uses therof
KR20230129639A (ko) * 2022-03-02 2023-09-11 연세대학교 산학협력단 이중작용 pde5 억제제/질산유기에스터의 국소 혈류 증진을 위한 경피 투약 형태

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5761734B2 (es) * 1973-09-27 1982-12-25 Takeda Chemical Industries Ltd
JPS5761734A (en) * 1980-10-02 1982-04-14 Teijin Ltd Spun like fabric
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
JP3713783B2 (ja) * 1995-01-20 2005-11-09 大正製薬株式会社 1H−ピラゾロ[3,4−d]ピリミジン−4−オン誘導体
SK285991B6 (sk) * 1997-04-25 2008-01-07 Pfizer Inc. Pyrazolopyrimidinóny, spôsob a medziprodukty na ich výrobu, ich použitie a farmaceutické a veterinárne kompozície na ich báze
EA200000969A1 (ru) * 1998-04-20 2001-06-25 Пфайзер Инк. ИНГИБИТОРЫ цГМБ ФДЭ5 НА ОСНОВЕ ПИРАЗОЛПИРИМИДИНОНА ДЛЯ ЛЕЧЕНИЯ ПОЛОВЫХ ДИСФУНКЦИЙ
KR100358083B1 (ko) * 2000-02-17 2002-10-25 에스케이케미칼주식회사 피롤로피리미디논 유도체와 이의 제조방법, 그리고 이의용도

Also Published As

Publication number Publication date
CA2400268A1 (en) 2001-08-23
DE60103508D1 (de) 2004-07-01
EP1257553B1 (en) 2004-05-26
KR20010083637A (ko) 2001-09-01
TR200402101T4 (tr) 2004-10-21
NZ520842A (en) 2004-04-30
RU2263676C2 (ru) 2005-11-10
DE60103508T2 (de) 2005-06-30
BRPI0108395B8 (pt) 2021-05-25
AU3614001A (en) 2001-08-27
HU230344B1 (hu) 2016-02-29
HUP0300527A2 (hu) 2003-07-28
BR0108395A (pt) 2003-03-11
KR100358083B1 (ko) 2002-10-25
ZA200206587B (en) 2003-10-09
MXPA02007942A (es) 2004-09-10
CA2400268C (en) 2009-08-18
CN1312153C (zh) 2007-04-25
CN1422271A (zh) 2003-06-04
EP1257553A1 (en) 2002-11-20
DK1257553T3 (da) 2004-10-04
HUP0300527A3 (en) 2012-10-29
IL151234A (en) 2010-05-17
AU2001236140B2 (en) 2006-01-12
NO20023823D0 (no) 2002-08-13
WO2001060825A1 (en) 2001-08-23
AU2001236140B9 (en) 2006-08-31
BRPI0108395B1 (pt) 2017-06-06
US20030171361A1 (en) 2003-09-11
PL210796B1 (pl) 2012-03-30
US6962911B2 (en) 2005-11-08
NO20023823L (no) 2002-10-09
JP2003523344A (ja) 2003-08-05
PT1257553E (pt) 2004-10-29
RU2002124872A (ru) 2004-01-10
ATE267829T1 (de) 2004-06-15
PL358188A1 (en) 2004-08-09
ES2222344T3 (es) 2005-02-01
IL151234A0 (en) 2003-04-10
JP4845076B2 (ja) 2011-12-28

Similar Documents

Publication Publication Date Title
NO323553B1 (no) Fremgangsmate for tilvirkning og bruk av pyrrolopyrimidinon-derivater
AU2001236140A1 (en) Pyrrolopyrimidinone derivatives, process of preparation and use
JP3000674B2 (ja) ジヒドロピラゾロピロール類
AU636816B2 (en) Pyrazolopyrimidinone antianginal agents
US6235742B1 (en) 5-substituted pyrazolo[4,3-D]pyrimidin-7-ones
US5346901A (en) Pyrazolopyrimidinone antianginal agents
US7501438B2 (en) Pyridoimidazole derivatives
NO178029B (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive pyrazolopyrimidinoner
CZ20012697A3 (cs) Deriváty pyrazolkarboxylové kyseliny, způsob jejich přípravy a farmaceutické prostředky, které je obsahují
AU2020207089A1 (en) 15-PGDH inhibitor
CA1248532A (en) Pyrazolo¬3,4-b|pyridine derivatives and process for producing them
FI64597C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 5-ubstituerade 1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-karbox ylyror av motsvarande nya nitriler
EP3619209A1 (en) Substituted bicyclic heterocyclic compounds as nadph oxidase inhibitors
KR20110028445A (ko) 퇴행성 및 염증성 질병의 치료에 유용한 축합된 피라진 화합물
IE922342A1 (en) Imidazo[2,1-b]benzothiazole-3-acetamide derivatives, their¹preparation and their use in therapeutics
WO2001087888A1 (en) Pyrazolopyrimidinone derivatives, process for their preparation and their use
TWI300778B (en) Pyrrolopyrimidinone derivatives, process of preparation and use
KR100297814B1 (ko) 피라졸로피리미디논유도체와이의제조방법그리고이의용도
US20050130983A1 (en) Pyrrolopyrimidinone derivatives, process for preparation thereof, and method of using and composition comprising them
US20010039347A1 (en) Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4h-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
EP1362858A1 (en) Pyrrolopyrimidinone derivates, process of preparation and use

Legal Events

Date Code Title Description
MK1K Patent expired